( P ro)renin receptor (PRR) is highly expressed in many tissues, including those of the heart and brain, 1,2 and plays an important role in the maintenance of cardiovascular homeostasis in the periphery. 3,4 However, the role of PRR in the brain remains poorly understood. Despite intrinsically low renin concentrations in the brain, the ability of renin to signal in a similar manner to angiotensin (Ang)-II, 5 coupled with the presence of PRR in the brain cardioregulatory areas, 2,6 suggests a role for PRR in central cardiovascular control. Our previous study revealed that PRR expression is significantly increased in the nucleus of the solitary tract (NTS) and the supraoptic nucleus (SON) of spontaneously hypertensive rats (SHR) compared with normotensive Wistar Kyoto (WKY) controls. 6 Genetic knockdown of PRR in the SHR SON 6 and other cardioregulatory regions, such as the subfornical organ (SFO) 7 in hypertensive rats, resulted in a reduction of blood pressure (BP). However, the role of NTS PRR in BP control and its precise mechanisms remain elusive.
Results
First, we investigated the effect of chronic PRR knockdown in the NTS on BP. Recombinant adeno-associated virus type 2 (AAV2)-PRR-small hairpain RNA (shRNA) gene transfer induced a significant increase in mean arterial pressure (MAP) in SHR (shRNA, 173±4; Control, 151±6 mm Hg; P<0.05; Figure 1A ), but not in WKY rats ( Figure S1 in the online-only Data Supplement). We observed a rightward shift in the SHR PRR-shRNA baroreflex curve, as the baroreflex gain reset to higher pressure, with no significant change in the maximum gain (PRR-shRNA, 3.05±0.42; vs Control, 2.33±0.26; Figure 1B ; Table S1 in the online-only Data Supplement). Successful transduction of the NTS cells at the level of the calamus scriptorius with AAV viral vector was confirmed by the reporter gene green fluorescent protein ( Figure S1B ). Immunostaining demonstrated decreased PRR activity in the PRR-shRNA-injected animals ( Figure S2 ). In addition, quantitative real-time polymerase chain reaction from the NTS samples revealed significant decreases in mRNA levels of IκB kinase (nfkbia, 43%), nuclear factor κB (NF-κB; nfkb1, 21%), Ccl5 (32%), tumor necrosis factor-α (TNF-α, 32%), and IL-6 (55%) in PRR-shRNA-injected SHR compared with controls. These changes were associated with 45% decreases in PRR mRNA level ( Figure 1C ). No changes were observed in IL1β and IL10 mRNA levels (not shown).
Because PRR knockdown in the SHR NTS lead to decreased inflammatory mediators, implying the possibility of PRR regulating BP via control of cytokines expression, we then compared cytokine mRNA levels in the NTS of WKY rats, SHR, and PRR-shRNA-injected SHR. We observed decreased mRNA levels of IL-6 (45%), TNF-α (55%), Ccl5 (35%), and NF-κB (35%) in the SHR compared with WKY rats ( Figure S3 , *P<0.05). PRR knockdown resulted in a further decrease in the mRNA levels of these genes. In contrast to this, IκB kinase (nfkbia) mRNA was increased by 40% in the SHR compared with WKY rats, suggesting a compensatory mechanism in the SHR restraining further decrease in NF-κB expression. However, PRR knockdown resulted in a 43% decrease in nfkbia mRNA expression compared with the control SHR ( Figure S3 ).
Next, we studied the effect of acute NTS PRR activation by renin on MAP and heart rate (HR). Bilateral injections of human renin (0.02-2 pmol in 200 nL/side) in the SHR NTS resulted in an immediate dose-dependent decrease in MAP and HR (0.02 pmol: ΔMAP, −16±4 mm Hg, ΔHR, −14±7 bpm; 0.2 pmol: ΔMAP, −33±8 mm Hg, ΔHR, −27±7 bpm; 2 pmol: ΔMAP, −38±4 mm Hg, ΔHR, −40±10 bpm; Figure 2A and 2B). In contrast, identical injections in the NTS of WKY rats produced negligible effects on MAP and HR (0.02 pmol: ΔMAP, 7±1 mm Hg, ΔHR, 2±4 bpm; 0.2 pmol: ΔMAP, 1±4 mm Hg, ΔHR, −8±8 bpm; 2 pmol: ΔMAP, −4±3 mm Hg, ΔHR, −12±7 bpm; Figure 2A and 2B). Because we observed significant changes only in the SHR, further studies were carried out only in this rat strain. Preadministration of prorenin handle region peptide (200 pmol) into the SHR NTS attenuated the human renin (2 pmol)-induced depressor and bradycardia effects by ≈80% ( Figure 2C ). However, preinjection of losartan (200 pmol), or Ang-II type 2 (AT2) receptor blocker PD123319 (2 nmol) did not influence the effects of human renin in the NTS of SHR ( Figure 2C ). Figure 2D shows the site of drug injections. Figure 1 . Effects of chronic knockdown of (pro) renin receptor (PRR) in the the nucleus of the solitary tract (NTS) of spontaneously hypertensive rat. PRR knockdown resulted in a significant increase in mean arterial pressure (MAP; A), and shifted the cardiac baroreflex curve to higher MAP with no change in the maximum gain (B). Recombinant adeno-associated virus type 2 (AAV2)-PRR-shRNA gene transfer in the NTS significantly decreased mRNA levels of nuclear factor κ B , interleukin (IL)-6, tumor necrosis factor (TNF)-α, C-C motif ligand 5 (Ccl5), and PRR (C). HR indicates heart rate. March 2013
Finally, we investigated the mechanisms of PRR activation using primary neuronal cultures because PRR is primarily distributed in neurons of the brain cardiovascular areas. 6 Incubation of SHR neuronal cultures with prorenin (100 nmol/L) resulted in a time-dependent increase in phosphorylation of IκBα, the inhibitor of NF-κB α subunit, with maximum effect at 30 minutes after prorenin incubation ( Figure 3A) . IκB can deactivate NF-κB nuclear localization signal by physically masking it, 12 and phosphorylatyion of IκBα results in IκB degradation and subsequent NF-κB activation. Immunostaining demonstrated that prorenin treatment induced translocation of NF-κB P65 from cytosol to the nucleus ( Figure 3B ), indicating NF-κB activation. This was confirmed by TransAM ELISA showing the increase of NF-κB P65 content in the nuclear extract after prorenin treatment ( Figure  3C ). On extension of the prorenin incubation time, NF-κB and IκB kinase mRNA showed a time-dependent increase ( Figure  S4 ), with maximum effect at 3 hours ( Figure S4 and Figure  3D ). Similarly, prorenin (100 nmol/L) treatment caused timedependent increases in the mRNA of inflammatory mediators, with maximum increases of IL1β, IL-6, TNF-α, Ccl5, and IL10 in 3 hours ( Figure S5 ). We then coincubated neuronal cultures with prorenin (100 nmol/L), with or without the AT1 receptor blocker losartan (2 µmol/L), the NF-κB activation inhibitor quinazoline (15 µmol/L), or curcumin (50 µmol/L) for 3 hours. Real-time polymerase chain reaction showed significantly higher mRNA levels for IL-1β (250-fold), IL-6 (35-fold), TNF-α (32-fold), Ccl5 (12-fold), and IL10 (7-fold) in prorenin-treated cells. These stimulatory effects on cytokines were almost completely (>90%) blocked by quinazoline and curcumin, but not by losartan (Figure 4) . Similarly, human renin (20 nmol/L) also resulted in stimulation of cytokines, but to a much higher degree (IL1β, 4000-fold; IL-6, 400-fold; TNF-α, 400-fold; Ccl5, 50-fold, and IL10, 20-fold; Figure S6) . Finally, we selectively tested the effect of prorenin on IL-6 and TNF-α secretion into the cell culture medium. We observed that increases in the IL-6 and TNF-α mRNA after prorenin treatment were associated with NF-κB-dependent release of IL-6 (Control, undetectable; prorenin, 230 pg/mL) and TNF-α (Control, undetectable; prorenin, 133 pg/mL) into the cell culture medium ( Figure 4B ).
Discussion
The current study reports several novel findings: (1) The NTS PRR contributes to the maintenance of the set-point of arterial pressure; and (2) PRR cardiovascular effects in the NTS are Ang II-independent, and involve neuronal NF-κB-cytokine signaling.
We have previously demonstrated increased PRR expression in the NTS of SHR compared with WKY rats. 6 Here, we report that chronic knockdown of PRR in the NTS exacerbated hypertension in SHR, despite having no effect in the WKY rats. Furthermore, acute PRR activation in the NTS produced negligible effects on MAP and HR in the WKY rats, different from previous observations. 13 Additionally, we showed a profoundly augmented depressor effect of renin in the SHR, independent of a PRR-dependent Ang-II generation, as specific blockade of AT1 and AT2 receptors failed to abolish the effects of renin. Therefore, although the human renin, as used in this study, can bind to rat PRR with a comparable affinity, it is unable to act on the endogenous rat angiotensinogen to generate Ang-II.
14 Furthermore, prorenin handle region peptide, a PRR inhibitor, attenuated renin actions by 80%. However, off-target effects of renin cannot be completely ruled out in view of the specificity of prorenin handle region peptide for the PRR. 15 Development of a specific PRR antagonist must await this confirmation.
Because activation of PRR in the NTS resulted in a depressor effect, and silencing of this receptor in the NTS neurons further increased the SHR BP, the intrinsic baseline upregulation of endogenous PRR in the NTS of SHR suggests a compensatory mechanism of hypertension, acting to reduce further BP elevation. The restraining influence of certain neuronal phenotypes in the NTS on chronic BP has previously been reported. 16, 17 For example, the enzyme phosphoinositide 3-kinase (PI3K), thought to be involved in Ang-II-mediated neuronal signaling, is elevated in the NTS and paraventricular nucleus (PVN) of SHR. 17, 18 However, chronic neuronal blockade of PI3K in the NTS is prohypertensive, 17 whereas it is antihypertensive in the PVN of SHR. 18 Similarly, chronic silencing of catecholaminergic neurons in the NTS increases BP more profoundly in the SHR. 16 The opposing effects of activation of the NTS versus the PVN/rostral ventrolateral medulla (RVLM)/SFO/SON are generally attributed to the notion that the NTS is considered an inhibitory cardioregulatory nucleus because its activation (by baro-input, for example) decreases the BP, whereas the activation of the PVN, RVLM, and SFO/SON (ie, the excitatory cardioregulatory nuclei) has an opposite cardiovascular effect. 19 In line with this, PRR knockdown in the excitatory SFO and SON is sympathoinhibitory and alleviates hypertension. 6, 7 However, and similarly to the PI3K, upregulation of PRR in certain NTS neuronal subtypes, which seem to have a restraining influence on BP within the NTS, may promote compensatory activation of the NTS because the system attempts to restore the cardiovascular homeostasis and prevent even higher BP development. The question now, however, is why the SHR BP remains elevated, despite the intrinsic compensatory PRR upregulation in the NTS. From this, it follows that the NTS PRR upregulation, however beneficial, may be only 1 of the compensatory mechanisms attempting to re-establish the cardiovascular homeostasis in the SHR. Our current study also demonstrates the involvement of specific cytokines/chemokines in the NTS PRR signaling. Inflammatory status of the brain is now a well-established hallmark of essential hypertension. 10, 20 We observed a significant decrease in the inflammatory markers IL-6, TNF-α, and Ccl5, as well as their transcription regulator NF-κB, in the NTS of the SHR compared with the WKY rats. Consistent with this, IL-6 and Ccl5 exert cardiovascular actions via modulation of sympathetic neuronal outflow in the central nervous system. 10 For example, acute microinjection of Ccl5 in the NTS induces a profound decrease in BP in the SHR but has only a minor effect on the WKY rats. 10 Here, we showed that the chronic PRR knockdown in SHR resulted in further downregulation in the expression of Ccl5, while exacerbating hypertension in the SHR. Therefore, downregulation of Ccl5 in the NTS of SHR may be prohypertensive, as previously suggested. 10 Furthermore, activation of neuronal PRR in vitro resulted in increased NF-κB activation within 5 minutes of incubation, which is also the time frame of the acute depressor effects of a single renin injection in the NTS. Therefore, the acute effects of renin may also be mediated via the cytokine/chemokine signaling. However, we acknowledge the lack of evidence to support this hypothesis at present, and the NTS PRR activation may also have a cytokine-independent effect beyond the scope of the current study, warranting further investigation.
Collectively, these studies suggest that chronic PRR upregulation in the NTS of SHR acts as a compensatory mechanism attempting to normalize the levels of specific cytokines/chemokines. Considering the putative restraining role of the NTS neurons on chronic BP, without this mechanism of upregulation of the PRR in the NTS, the cytokine/chemokine levels may be even lower and the BP even higher in SHR. Therefore, the inherent overexpression of PRR in the NTS of SHR may exert a protective effect by preventing further increases in BP and HR.
Perspectives
PRR is the newest member of the renin-angiotensin system, the impact of which on pathophysiology of cardiovascular disease and diabetes mellitus is increasingly evident. However, the role of this receptor in neural control of cardiovascular function remains to be fully appreciated. Our study demonstrated that chronic knockdown of PRR in the SHR NTS exacerbates hypertension in an NF-κB-cytokinemediated and AT1 receptor-independent manner. Thus, the current study provides support for a protective role of PRR in development of hypertension in SHR. Further studies should focus on the types of neurons involved in the NTS PRR signaling.
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What Is New?
• Τhe nucleus of the solitary tract (NTS) (pro)renin receptor (PRR) regulates both short-and long-term cardiovascular homeostasis
• NTS PRRs present a protective effect against hypertension by an angiotensin II-independent pathway
• PRR signaling involves nuclear factor κB-cytokine pathway What Is Relevant?
• Determination of the modulatory factors and investigation of the neurons involved in the NTS PRR activation may provide a pathway toward development of powerful intervention tools for lowering arterial pressure.
Summary
Chronic knockdown of NTS PRR in the spontaneously hypertensive rat elevates blood pressure and shifts the set-point of arterial pressure to a higher level; in line with this, acute prorenin injections in the NTS induce hypotensive and bradycardic effects. In addition, neuronal PRR signaling is nuclear factor κB-cytokine signaling-dependent. This study suggests that NTS PRR may be a compensatory mechanism of hypertension, acting to re-establish blood pressure homeostasis in a manner mediated by nuclear factor κB-cytokine signaling pathway. 
Materials and Methods

Animals
All Wistar-Kyoto rats (WKY) and SHR were purchased from Charles River Laboratories (Wilmington, MA). Rats were housed individually and kept on a 12h: 12h light-dark cycle in a climate-controlled room. Rat chow (Harlan Tekland) and water were provided ad libitum. All the animal experiments followed protocols approved by the University of Florida Institutional Animal Care and Use Committee.
Plasmid construction and production of AAV vectors containing PRR-shRNA
A synthetic complementary DNA encoding small hairpin RNA (shRNA) targeted rat PRR mRNA or scrambled (Sc) DNA, containing the same nucleotides as the PRR-shRNA DNA template but in a completely different arrangement and not targeted to any rat gene, was designed and cloned into an AAV vector, PTR-UF11, under the control of human U6 promoter 1 . A GFP reporter gene under the control of chicken beta-actin (CBA) promoter was cloned upstream of the shRNA expression cassette to enable visualization of expression from the vector, confirming transgene delivery. Details of plasmid construction and generation of AAV2-PRR-shRNA are as described previously 1 .
Chronic PRR knockdown using AAV2-PRR-shRNA in the Nucleus of the solitary tract (NTS)
PRR knockdown was performed using AAV2-PRR-shRNA mediated gene transfer. Eight-week-old male SHR were randomly divided into two groups. They were anesthetized and subjected to bilateral injection into the NTS with experimental virus, AAV2-PRR-shRNA, or control virus, AAV2-Sc-shRNA. AAV2 virus {2x10 8 genome containing virus particles (gc) in 200 nL} was injected into each injection site at the level of the calamus scriptorius ±400 µm from the midline, and 600 µm ventral to the dorsal surface 2 . Eight weeks following microinjection, animals were subjected to BP and autonomic function measurement as described below.
Blood pressure (BP) and baroreflex measurement in PRR chronic knockdown SHR
All SHR were anaesthetized under urethane and implanted with catheters (PE-10 connected to a PE-50) into both the femoral artery, for BP measurement, and femoral vein, for drug delivery. The catheters were tunneled subcutaneously into the back of the neck to allow access when the animal was conscious. The arterial catheter was connected to a strain-gauge transducer coupled to a computer-based data acquisition system (PowerLab, ADInstruments) in order to record pulsatile arterial pressure (PAP). Mean arterial pressure (MAP) and heart rate (HR) were simultaneously calculated by the software LabChart (ADInstruments) and continuously displayed. After 24h the cardiovascular parameters were evaluated in unanesthetized animals.
The baroreflex control of HR was determined by recording reflex HR changes in response to transient increases or decreases in mean arterial pressure (MAP) produced by bolus injections of phenylephrine (0.5 and 1 µg/0.1 mL, iv; baroreflex bradycardia) or sodium nitroprusside (0.5 and 1 µg/0.1 mL, iv; baroreflex tachycardia) as previously described 3 . In each animal, the ratio between changes in HR (as pulse interval, ∆PI, ms) and changes in MAP (∆MAP, mmHg) was used as index of baroreceptor sensitivity (BSI). In addition, the baroreflex MAP-HR relationship was evaluated using the logistic sigmoid function curve for the best fit as described by the following equation,
where y is HR, x is MAP, A 1 is the y range, A 2 is the gain coefficient, A 3 is MAP at the midpoint (operating point), and A 4 is y at the bottom plateau. The function curves were constructed as described previously 4, 5 and the goodness of fit of each sigmoidal curve to the raw data points was measured by the correlation coefficient (R 2 ). Only sigmoidal curves with R 2 > 0.91 were considered for further analysis. The results of the sigmoidal curves are represented in table S1.
In vivo acute injection of recombinant human renin into the NTS
Twelve-week-old male WKY rats and SHR were implanted with telemetry transmitters (DSI International) for BP measurement as described previously 7 . Following one week of recovery, rats were anaesthetized with a urethane/a-chloralose mixture (800 mg/kg of urethane, 80 mg/kg of a-chloralose, i.p.; Sigma Aldrich), and the head was positioned in a stereotaxic frame. Bilateral microinjection (200 nL/ side) of the vehicle (Tris-NaCl, pH 7.4), recombinant human renin (Innovative, Michigan, USA, 0.02-2 pmol in 200nL/side) and losartan (200 pmol in 200nL/side) were made at the level of the calamus scriptorius, ±400 µm from the midline, and 600 µm ventral to the dorsal surface 2 , using a glass micropipette (Harvard Apparatus), with the head held firmly in the stereotaxic frame and the nose pointing downwards at 45º. Calamus scriptorius was used as a landmark to direct micropipettes into sites known to contain baroreceptive neurons in the rat 8, 9 . The losartan dose used here was previously shown to completely block Ang II effects in the NTS 10 . The AT2R blocker (2 nmol in 200 nL/side), Mas receptor antagonist, A779 (200 pmol in 200 nL/side), or prorenin handle region peptide (HRP, 200 pmol in 200nL/side) were injected 5 minutes prior to injection of renin at the same site. The micropipette was placed into the NTS using a micromanipulator. The microinjection volume was determined by viewing the movement of the meniscus through a binocular microscope fitted with a calibrated eyepiece graticule. The microinjections were completed over a period of 1 minute. Immediate effects of the microinjections on the SBP and HR were monitored, and these returned to the baseline values within 5 minutes. Blue dye (60-80 nl) was microinjected unilaterally into the NTS at the end of each experiment to mark the injection site.
PRR immunoactivity in the NTS
Fresh brainstem ccoronal sections containing the NTS was cut and PRR staining was performed as described previously 1 .
4
RNA isolation from the NTS
Rats were euthanized, brains were dissected, and the NTS regions were punched out and subjected to RNA isolation, using RNeasy mini kit (Qiagen, Valencia, CA, USA) following the manufacturer's instructions.
Preparation of neuronal cultures
Neuronal cultures were made from the hypothalamus and brainstem of one-day-old SHR as described previously 11 . Neuronal cultures contain more than 90% neurons (remaining cells are primarily astroglia). The cultures were maintained for 12-16 days prior to their use in experiments.
Measurement of phosphorylation of IKBα:
Western blot analysis was used to measure phosphorylated IKBα and endogenous control GAPDH using the neuronal cultures from SHR as described previously 1 . Briefly, neuronal cultures were incubated with or without human prorenin(100 nmol/L) (Innovative Research , Novi, Mi, USA) for differing time periods. Proteins were isolated, separated with 10% SDS-polyacrylamide gel electrophoresis, transferred to a nitrocellulose membrane, and probed with Phospho-IKBα primary antibody (cell signaling, Boston, MA, USA). Hybrid protein bands were detected with ECL™ Western Blotting Detection Reagents. The membrane was stripped of phosphorylated ERK1/2 antibody and re-probed with GAPDH antibody to assay total protein levels. Protein bands representing Phospho-IKBα were quantified using the NIH ImageJ program (Bethseda, Maryland, USA; http://rsb.info.nih.gov/ij) phosphorylated IKBα were normalized to GAPDH.
Measurement of prorenin stimulation effect on cytokines and related genes
Neuronal cultures incubated with 100 nmol/L of prorenin or vehicle control for differing time periods (1h, 3h, 6h, 12h and 24 h). Cells were collected and quantitative real-time PCR was performed to measure mRNA levels of cytokines including: interleukin(IL)1β, tumor necrosis factor-alpha (TNFα), IL6, chemokine C-C ligand 5 (Ccl5), IL10, NF-КB subunit P50 (nfkb1), I-kappa B kinase (IKK) subunit nfkbia using specific primers and probes (Applied Biosystems, Foster City, CA, USA) in the Step One Plus™ Real Time PCR System (Applied Biosystems). Based on the results from above time-course experiment, the maximum increase in cytokine mRNA levels occurred 3h following prorenin incubation. We then co-incubated neuronal cultures with 100 nmol/L of prorenin or 20 nmol/L of renin with or without AT1R blocker, losartan (2 µmol/L), NF-КB inhibitor quinazoline (15 µmol/L), or curcumin (50 µmol/L) for 3h, the mRNA levels of cytokines, NF-ҠB and IKK were determined by quantitative RT-PCR as described above.
Each set of experiments was performed using three separate culture dishes, and all cDNA samples were assayed in triplicate. The whole experiment was repeated at least 3 times. Data were normalized to GAPDH RNA. 
NF-ҠB DNA binding ELISA
DNA binding activity of NF-κB p65 was measured using TransAM NF-κB p65 kits (Active Motif) following the manufacturer's instructions. Briefly, 12-day-old primary neuronal cultures were incubated with either prorenin (100 nmol/L) or same volume of PBS for 30 min, the cells were collected and nuclear extract was isolated, and then 20 μg of nuclear protein samples was incubated for 1 h in a 96-well plate coated with an oligonucleotide containing a NF-ҠB consensus binding site (5′-GGGACTTTCC-3′), to which NF-ҠB contained in nuclear extracts specifically binds. After washing, an antibody specific for p65 (1/1000 dilution) was added to these wells and incubated for 1 h. After incubation for 1 h with a secondary HRP-conjugated antibody (1/1000 dilution), specific binding was detected by colorimetric estimation at 450 nm with a reference wavelength of 655 nm.
Immunocytochemistry of PRR and NF-ҠB P65 in primary neuronal cultures
Immunocytochemistry of PRR and NF-ҠB P65 was performed as described previously 12 . Briefly, neuronal cultures were fixed with 4% paraformaldhyde in PBS. incubated with 1% bovine serum albumin in PBS for 30 min to block non-specific binding, and then cultures were rinsed with PBS containing 0.3% Triton X-100 (PBST). They were then incubated with a 1:100 dilution of goat anti-ATP6AP2, a PRR specific antibody (NOVUS Biologicals, Littleton, CO, USA) and a 1:300 dilution of rabbit anti-NF-ҠB P65 antibody (cell signaling, Boston, MA, USA). This was followed by incubation with secondary antibodies. Cells were examined and photographed with the use of an Olympus BX41 microscope.
Assay of secreted cytokines
Neuronal cultures were pre-incubated with either AT1R blocker, losartan (1 µmol/L), or NF-ҠB activation inhibitor, quinazoline (15 µmol/L), or curcumin (50 µmol/L). Thirty minutes later, prorenin was added into the culture medium (100 nmol/L). Two further groups of neuronal cultures were treated with either identical concentrations of prorenin or vehicle control. Six hours following prorenin incubation, culture medium was collected, and processed to measure the production of TNFa and IL6 using ELISA kit (Invitrogen, Grand Island, NY, USA) exactly following the manufacturer's instructions. We selected incubation 6 h instead of 3h, which showed the maximum increase in the mRNA increase because the protein expression is slower than mRNA transcription.
Statistical analysis
All data are expressed as means ± S.E.M. Statistical significance was evaluated with the use of one-way ANOVA, two-way ANOVA and unpaired Students t test. Differences were considered to be significant at p < 0.05. 
